PIZZOLO, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 17.140
EU - Europa 14.590
AS - Asia 4.733
OC - Oceania 33
SA - Sud America 33
Continente sconosciuto - Info sul continente non disponibili 18
AF - Africa 14
Totale 36.561
Nazione #
US - Stati Uniti d'America 17.089
GB - Regno Unito 6.037
CN - Cina 3.672
SE - Svezia 1.480
IT - Italia 1.395
FR - Francia 1.169
IE - Irlanda 1.100
DE - Germania 1.006
FI - Finlandia 980
RU - Federazione Russa 749
SG - Singapore 579
UA - Ucraina 396
BE - Belgio 110
JP - Giappone 99
TR - Turchia 90
KR - Corea 61
IR - Iran 58
IN - India 57
VN - Vietnam 44
CA - Canada 41
NL - Olanda 34
AU - Australia 26
CH - Svizzera 20
BR - Brasile 18
CZ - Repubblica Ceca 17
RO - Romania 17
ES - Italia 14
EU - Europa 13
PL - Polonia 11
BG - Bulgaria 10
IL - Israele 8
IQ - Iraq 8
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
HK - Hong Kong 6
HU - Ungheria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
MX - Messico 5
NO - Norvegia 5
NP - Nepal 5
PE - Perù 5
ID - Indonesia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
SA - Arabia Saudita 4
AL - Albania 3
AR - Argentina 3
BD - Bangladesh 3
MY - Malesia 3
PA - Panama 3
PK - Pakistan 3
ZA - Sudafrica 3
BY - Bielorussia 2
CO - Colombia 2
DZ - Algeria 2
HR - Croazia 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MD - Moldavia 2
PT - Portogallo 2
UZ - Uzbekistan 2
YE - Yemen 2
CM - Camerun 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MS - Montserrat 1
NG - Nigeria 1
PH - Filippine 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 36.561
Città #
Southend 5.315
Jacksonville 3.693
Chandler 2.494
Woodbridge 2.117
Ann Arbor 1.395
Ashburn 1.187
Houston 1.180
Dublin 1.098
Wilmington 474
Beijing 473
Lawrence 446
Princeton 446
Jinan 444
Singapore 436
Nanjing 412
Shenyang 349
New York 276
Hebei 230
Boardman 200
Verona 194
Sindelfingen 185
Tianjin 172
Helsinki 150
Changsha 145
Zhengzhou 144
Nanchang 139
Haikou 131
Milan 123
Ningbo 122
Hangzhou 116
Taizhou 111
Jiaxing 106
Brussels 105
Philadelphia 85
Taiyuan 81
Guangzhou 79
Seattle 77
Falls Church 75
Norwalk 71
Washington 70
Lancaster 65
Seoul 59
Dearborn 57
Auburn Hills 56
Fuzhou 56
Düsseldorf 51
Redmond 49
Rome 48
Fairfield 47
Los Angeles 46
Lanzhou 44
Dong Ket 30
Leawood 29
San Francisco 28
Cambridge 27
Redwood City 27
Tokyo 26
Kochi 24
Kent 22
Zanjan 22
Bologna 20
Chicago 19
Tappahannock 19
Toronto 18
Paris 17
San Mateo 17
Moscow 16
Clearwater 15
San Diego 14
Ardabil 13
Kemerovo 13
São Paulo 13
Detroit 12
Edinburgh 12
Florence 12
Manchester 12
Padova 12
Columbus 11
Genova 11
Napoli 11
Riva 11
Augusta 10
Groningen 10
Lonigo 10
Melbourne 10
Nürnberg 10
London 9
Madrid 9
Ypsilanti 9
Brno 8
Dallas 8
Fremont 8
Genoa 8
Shinchiba 8
Amsterdam 7
Canberra 7
Modena 7
Palermo 7
Qingdao 7
Sacramento 7
Totale 26.416
Nome #
La citometria a flusso in Ematologia: aspetti tecnici e metodologici 421
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 354
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 320
Valutazione immunofenotipica della malattia minima residua (MRD) nella leucemia acuta linfoblastica dell'adulto 266
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 259
IFNalpha-producing bone marrow mesenchymal stem cells (BM-MSCs) contrast tumor growth in a mouse myeloma model. 162
Interferon-alpha-engineered Multipotent Mesenchymal Stromal Cells for the treatment of myeloma 161
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 154
Caratterizzazione immunofenotipica: principi ed applicazioni in Ematologia 148
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 145
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 144
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 139
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 132
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 132
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 131
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 129
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 128
Fluoride resistant alpha-naphthyl acetate esterase and combined enzyme histochemistry in the study of normal and pathologic lymphoid tissues 126
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 126
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 125
Increased levels of soluble interleukin-2 receptor in the serum of patients with human immunodeficiency virus infection 125
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 123
Alpha (p55) and beta (p75) chains of the interleukin-2 receptor are expressed by AML blasts 122
I marcatori delle cellule linfoidi 122
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 121
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 121
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 121
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 120
Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy 119
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen 118
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 118
Expression of extracellular matrix molecules, proliferation markers and cyclin-dependent kinase inhibitors in inflamed tissues 117
An unusual case of acute leukaemia 117
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 116
[Lung diseases during the course of systemic diseases: current clinico-radiological problems (proceedings)] 116
High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia 116
a (p55) and b (p75) chains of interleukin-2 receptor are expressed by AML blasts 116
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 116
α-bisabolol is an effective proapoptotic agent against BCR-ABL+ cells in synergism with Imatinib and Nilotinib 116
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 115
Biological prognostic factors in indolent lymphoma 115
Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche 115
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 115
Blastic OKT6-positive proliferation preceding malignant histiocytosis 114
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 114
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 112
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 112
BCR-signaling profiles associated with prognosis and progression in B-CLL 112
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer 110
Immunohistochemical differentiation of follicular lymphoma from florid reactive follicular hyperplasia with monoclonal antibodies reactive on paraffin sections 109
Abnormal expansions of polyclonal large to small size granular lymphocytes: reactive or neoplastic process? 109
Hyaline-vascular type of Castleman's disease (angiofollicular lymph node hyperplasia) with monotypic plasma cells. An immunohistochemical study with monoclonal antibodies 109
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 108
Soluble forms of p55-IL-2R alpha, CD8, and CD30 molecules as markers of lymphoid cell activation in infectious mononucleosis 108
Acute lymphoblastic leukaemia after radiotherapy and adjuvant chemotherapy (CMF) for breast cancer. 108
A study of the crosstalk between CD30 and CXCR4 108
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 108
Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report 107
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 107
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 107
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 107
IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells 106
Acute leukemia and pregnancy. Case report 106
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 106
Espressione e ruolo funzionale di CD30/CD30L e Fas/FasL in cellule endoteliali umane 105
Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro 105
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 104
BONE MARROW-DERIVED STROMAL CELLS INHIBIT SPONTANEOUS APOPTOSIS IN NORMAL AND NEOPLASTIC THYMOCYTES 104
G-CSF-stimulated neutrophils are a prominent source of functional BLyS 104
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 103
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 103
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 103
Detection of calbindin-D immunoreactivity in human follicular dendritic cells 103
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 103
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 103
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 103
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 102
Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases 102
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 102
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 102
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 102
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis 102
Expression and role of CD30/CD30L and Fas/FasL in human endothelial cells 101
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 101
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 101
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 101
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 100
The Sesquiterpene Oil {alpha}-Bisabolol Induces Apoptosis of B-Chronic Lymphocytic Leukemia Primary Cells 100
Pro-apoptotic activity of α-bisabolol in preclinical models of primary human acute leukemia cells 100
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 100
A rapid immunostaining method for frozen sections 99
Terminal transferase expression in relapsed acute myeloid leukaemia 99
Homing and Efficacy Assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmocytoma model 99
Underdiagnosed systemic mastocytosis: The role of flow cytometry 99
BCR-signaling profiles associated with prognosis and progression in B-CLL 99
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 99
Immuno-histological analysis of bone marrow involvement in lymphoproliferative disorders 98
Abnormal expression of the p53-binding protein MDM2 in Hodgkin's disease 98
Multipotent stem cell with neural differentiation potential reside in the leptomeninges 98
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 98
Totale 12.354
Categoria #
all - tutte 105.222
article - articoli 75.636
book - libri 0
conference - conferenze 28.242
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.344
Totale 210.444


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.095 0 96 48 441 313 695 399 499 218 513 173 700
2020/20214.737 316 736 232 501 538 615 58 420 373 40 704 204
2021/20223.825 332 1.097 44 267 212 118 76 204 135 142 390 808
2022/20237.272 585 586 660 1.299 744 1.776 59 473 773 42 181 94
2023/20243.459 175 297 301 391 356 503 188 431 18 124 411 264
2024/2025870 603 267 0 0 0 0 0 0 0 0 0 0
Totale 36.871